Developmental Renal Filtration and Secretory Transport

Why Renal Clearance Needs More Than a Size Adjustment

A child's kidneys are smaller than an adult's, but kidney size alone does not determine how quickly they filter or secrete a drug. Renal function also changes during development. Glomerular filtration rate (GFR) matures with age, while the capacity for active tubular secretion depends on the growth and functional development of the relevant transport pathways. These processes can mature on different schedules.

A useful PBPK representation therefore separates three contributions: body-size scaling, organ growth, and functional maturation. For filtration, body surface area (BSA) is a practical size term, paired with a GFR maturation factor. For secretion, kidney growth can scale the amount of functional tissue, while a separate maturation factor represents transporter capacity per unit tissue. These are modelling choices, not claims that BSA or kidney mass alone directly determines function.

A Separable Model for Filtration and Secretion

Let \(\mathrm{GFR}_{\mathrm{ref,index}}\) be a mature reference GFR indexed to 1.73 m². For a child with BSA \(BSA_{\mathrm{child}}\), one simple model is:

This applies BSA scaling and functional maturation as separate factors. The BSA ratio is dimensionless, so the predicted GFR has the same units as the indexed reference, such as mL/min. The maturation factor should be supported by an appropriate developmental model or data; it should not be inserted a second time if the chosen reference or scaling already incorporates age-related maturation.

For secretion, define \(CL_{\mathrm{int,sec,ref}}\) as the mature reference intrinsic secretory clearance, in mL/min, relative to unbound plasma concentration. Let \(M_{\mathrm{kidney,child}}\) and \(M_{\mathrm{kidney,ref}}\) be the relevant total kidney masses. Under the simplifying assumption that capacity is proportional to kidney mass, a separable model is:

This uses organ growth to scale the amount of tissue and \(F_{\mathrm{sec}}(a)\) to scale its functional capacity per unit mass. Proportionality to kidney mass is a modelling assumption: it may not hold when nephron structure, transporter localization, or the distribution of functional tissue changes with age. If that assumption is unsuitable, replace the mass ratio with a better-supported measure of secretory tissue or capacity.

For a low drug concentration, assume filtration and secretion are linear and their contributions add. Let \(f_u\) be the unbound fraction in plasma, and assume it is constant over the concentration range considered. If tubular reabsorption is negligible, or has already been addressed separately, renal plasma clearance is:

The filtration term follows because filtration acts on unbound drug: the filtration rate is \(f_u C_p\,\mathrm{GFR}\), where \(C_p\) is total plasma concentration. The linear secretory rate is \(f_u C_p\,CL_{\mathrm{int,sec}}\). Dividing each rate by \(C_p\) gives the corresponding contribution to clearance. This convention defines \(CL_{\mathrm{int,sec}}\) relative to unbound plasma concentration; the factor \(f_u\) converts it to clearance relative to total plasma concentration.

Combining the Renal Contributions

The combined model follows from adding rates, not from adding maturation factors. Filtration and active secretion are parallel routes of removal under the stated linear assumptions. Their rates can be added, and dividing the combined rate by total plasma concentration yields the sum of their clearances.

A short derivation makes the assumptions explicit. Write total plasma concentration as \(C_p\). The filtration rate is \(f_u C_p\,\mathrm{GFR}\), and, in the linear range, the secretory rate is \(f_u C_p\,CL_{\mathrm{int,sec}}\). Their sum is the total renal removal rate when there is no additional reabsorption term. Dividing by \(C_p\) gives:

If net reabsorption is important, it cannot simply be ignored: represent its contribution with a suitable mechanism or data-supported net-clearance term. Likewise, secretion may not remain linear when transporter-mediated flux approaches saturation. The additive equation is not a universal renal-clearance identity; it is the result for this specified model.

Checking the Model and Choosing an Alternative

Before using the combined result in a PBPK simulation, check whether the input quantities and assumptions match the drug, age range, and intended output. In particular, confirm that the reference GFR is indexed in the units used by the BSA ratio, that the selected maturation factor corresponds to the same developmental-age definition, and that the kidney-mass ratio and secretory reference describe compatible tissue and capacity. An implausible discontinuity across ages or a predicted clearance inconsistent with available renal-function or excretion data signals a need to re-examine these choices.

The low-concentration secretion assumption also needs a check. For a single transporter described by Michaelis–Menten kinetics, secretory rate is \(V_{\max}C_u/(K_m+C_u)\), where \(C_u=f_u C_p\). At concentrations much smaller than \(K_m\), the rate is approximately \((V_{\max}/K_m)C_u\), so \(CL_{\mathrm{int,sec}}=V_{\max}/K_m\) is approximately constant. At concentrations approaching or exceeding \(K_m\), this linear approximation fails: the apparent secretion clearance depends on concentration. A PBPK model must then represent the saturable process rather than treating the linear clearance as constant.

A single \(F_{\mathrm{sec}}(a)\) is also a simplification when several transporters contribute. Tubular secretion requires coordinated steps, including movement into and out of tubular cells. If those steps have different age profiles, a single factor may misrepresent the effective pathway. More detailed transporter-specific or pathway-specific representations may be preferable when suitable data are available. A measured age-specific net renal clearance can be a useful empirical alternative, but it may not separate filtration from secretion and may not transfer reliably to different binding conditions or drug concentrations.

These approaches are not interchangeable in every application. The separated model is useful when the aim is to represent filtration and secretion as distinct mechanisms and the required parameters are defensible. Empirical clearance may be more appropriate when the available evidence supports the net process but not its components. A saturable representation is needed when concentrations make the linear approximation untenable.

Common Mistake: Treating Organ Growth as Maturation

A common mistake is to multiply adult secretory clearance by a kidney-mass ratio and assume that this fully captures development. This assumes that every unit of kidney tissue has mature transporter capacity at every age. The opposite mistake is to apply a maturation factor without any size term, implicitly giving a small child's kidneys the adult amount of functional tissue. The correction is to state and justify separate size and functional factors, then combine them only as specified by the model. A second frequent error is to apply \(f_u\) to a clearance that is already defined relative to total plasma concentration; check the clearance definition before applying binding.